Some meaningful rescheduling chatter • The good and bad in LA’s cannabis budget • & more …
An excerpt from recent editions of the Cannabis Wire Daily newsletter.
House Lawmakers Push Top FDA Official on Hemp Products and Cannabis Rescheduling
The conversation covered the proliferation of intoxicating hemp products, as well as the timeline for the federal review of whether to move cannabis from Schedule I to III.
Pew finds consistent support for legalization • Sen. Romney leads anti-rescheduling letter to DEA • Congressional Cannabis Caucus co-chairs push Garland • & more …
An excerpt from recent editions of the Cannabis Wire Daily newsletter.
Veterans, law enforcement groups send letters to DOJ to urge cannabis rescheduling • California regulators release detailed data dashboards • & more …
An excerpt from recent editions of the Cannabis Wire Daily newsletter.
What Else Is In HHS’ Cannabis Rescheduling Docs?
Many groups’ work, from CANNRA to the National Academies of Sciences, Engineering, and Medicine, informed a federal recommendation to reclassify cannabis.
NFL collabs on CBD clinical trial • Twelve AGs push DEA on rescheduling • Canada publishes new data on consumption trends • & more …
An excerpt from recent editions of the Cannabis Wire Daily newsletter.
UN human rights report highlights reforms • The politics of SAFER • Colorado preps for rescheduling • Minn. picks top cannabis regulator • & more …
An excerpt from recent editions of the Cannabis Wire Daily newsletter.
Congressional Research Service: DEA “likely” to follow HHS on rescheduling • Regulators push Congress to address “intoxicating hemp” in Farm Bill • Another lawsuit in New York • & more …
An excerpt from recent editions of the Cannabis Wire Daily newsletter.
Cannabis comes up at FDA listening session on tobacco • A GOP pushback on rescheduling • NY lawmakers push Hochul on tribal sales bill • & more …
An excerpt from recent editions of the Cannabis Wire Daily newsletter.